Enzyme Replacement Therapy Market Trends, Developments and Strategies 2025-2030: A Projected $15.44 Billion Landscape
February 07, 2025 06:19 ET
|
Research and Markets
Dublin, Feb. 07, 2025 (GLOBE NEWSWIRE) -- The "Enzyme Replacement Therapy Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2020-2030F" report has been added to ...
Rising Nutraceutical Needs Propel Protease Market, Projected Steady Expansion Through 2030 - Protease Market Set for Strong 5.9% Annual Growth
January 27, 2025 04:08 ET
|
Research and Markets
Dublin, Jan. 27, 2025 (GLOBE NEWSWIRE) -- The "Protease Market - Forecasts from 2025 to 2030" report has been added to ResearchAndMarkets.com's offering.The protease market is expected to grow at a...
Global Enzyme Replacement Therapy (ERT) Market Research Report 2023: A $14.79 Million Market in 2027 at a CAGR of 8.1% - Long-term Forecast to 2032
October 02, 2023 05:14 ET
|
Research and Markets
Dublin, Oct. 02, 2023 (GLOBE NEWSWIRE) -- The "Enzyme Replacement Therapy Global Market Report 2023" report has been added to ResearchAndMarkets.com's offering.The global enzyme replacement therapy...
Enzyme Replacement Therapy Market Set to Accelerate at a CAGR of 7.6%, Projected to Ascend to a Value of USD 20.6 Billion by 2032
June 27, 2023 09:38 ET
|
Acumen Research and Consulting
NEWYORK, June 27, 2023 (GLOBE NEWSWIRE) -- The Global Enzyme Replacement Therapy Market Size accounted for USD 10.1 Billion in 2022 and is projected to achieve a market size of USD 20.6 Billion by...
Amicus Therapeutics Announces Approval and Launch of New Pompe Disease Therapy in the European Union
June 27, 2023 07:00 ET
|
Amicus Therapeutics, Inc.
PHILADELPHIA, June 27, 2023 (GLOBE NEWSWIRE) -- Amicus Therapeutics (Nasdaq: FOLD), a patient-dedicated global biotechnology company focused on developing and commercializing novel medicines for...
First Wave BioPharma Announces First Patient Dosed in Phase 2 SPAN Clinical Trial of Enhanced Adrulipase Formulation
March 09, 2023 07:00 ET
|
First Wave BioPharma, Inc.
BOCA RATON, Fla., March 09, 2023 (GLOBE NEWSWIRE) -- First Wave BioPharma, Inc. (NASDAQ:FWBI) (“First Wave BioPharma” or the “Company”), a clinical-stage biopharmaceutical company specializing in...
Enzyme Replacement Therapy Market Size to Hit USD US$ 21.25 billion by 2030 | Growth Plus Reports
February 09, 2023 07:00 ET
|
Growth Plus Reports
Newark, New Castle, USA, Feb. 09, 2023 (GLOBE NEWSWIRE) -- According to the latest report published by Growth Plus Reports, the global Enzyme Replacement Therapy Market is expected to clock US$...
With 8.8% CAGR, Enzyme Replacement Therapy Market Size worth USD 20.58 Billion in 2028
October 12, 2022 05:34 ET
|
Fortune Business Insights
Pune, India, Oct. 12, 2022 (GLOBE NEWSWIRE) -- The global enzyme replacement therapy market size is predicted to reach USD 20.58 billion by 2028 at a CAGR of 8.8% during the forecast period. Fortune...
Fabry Disease Treatment Market to surpass USD 3.5 billion by 2030, says Global Market Insights Inc.
September 26, 2022 06:33 ET
|
Global Market Insights Inc.
Selbyville, Delaware, Sept. 26, 2022 (GLOBE NEWSWIRE) -- Fabry disease treatment market value is projected to cross USD 3.5 billion by 2030 , according to a new research report by Global Market...
Intracranial Therapeutic Delivery Market revenue will climb to US$ 4.2 Bn by the end of 2032 – Persistence Market Research
August 08, 2022 10:00 ET
|
Persistence Market Research
New York, Aug. 08, 2022 (GLOBE NEWSWIRE) -- The global intracranial therapeutic delivery market is currently valued at around US$ 1.6 Bn and is anticipated to progress at an impressive CAGR of 7.9%...